Tivic Health Takes Bioelectronic Medicine to HTLH
Will Demo FDA-Approved ClearUP that Treats Sinus Pain and Congestion from Colds, Flu, and Allergies…
Year: 2022
Rising Demand Further Disrupts U.S. Media, Network Firms
Industries reshaped by new content distributors are modernizing networks and systems to meet customer expectations,…
Harbor Capital Advisors Named a 2022 Top Workplace by the Chicago Tribune
Recognized for Human Capital and Cultural Excellence CHICAGO–(BUSINESS WIRE)–Harbor Capital Advisors, Inc. (“Harbor”), a premier…
Videra Health Uses AI-assisted Video Assessments to Help Signature Healthcare Services Improve Long-term Outcomes for Behavioral Health Patients
OREM, Utah–(BUSINESS WIRE)–Digital health software platform, Videra Health, announced today a partnership with California-based behavioral…
Mickey Bland Joins Connection Enterprise Solutions Group as President
New Leader to Drive Growth and Deliver Exceptional Service to Enterprise-level Customers MERRIMACK, N.H.–(BUSINESS WIRE)–Connection…
The United States Patent and Trademark Office (USPTO) Has Granted Certinal’s E-signature a Patent for Systems & Methods for Predicting and Moderating Signature Location Within Electronic Documents
WILMINGTON, Del.–(BUSINESS WIRE)–Certinal Inc. announces the US Patent & Trademark Office (USPTO) has granted Certinal…
Contentsquare Strengthens Tech & Impact Leadership with Key New Hires
New roles include Chief Information Officer, VP Digital Trust and Global Data Protection Officer (DPO),…
Insight Touts Solutions Integrator Strategy at Synergy23 Partner Summit
Annual partner conference draws nearly 600 technology experts to discuss how Insight’s vision for digital…
Virtual A3 TechCon Runs December 14 with the Latest in Industrial Motion Control and Motors
Experience actionable insights and expert knowledge designed to help improve industrial machinery, systems, and other…
Nucleai Launches New Multiplex Imaging Spatial Analysis Solution to Increase Reliability and Speed of Immunofluorescence Analysis for Drug Discovery and Development
TEL AVIV, Israel–(BUSINESS WIRE)–#Immunofluorescence–Nucleai, a leader in AI-powered spatial biology, today announced the expansion of…
Neosoma, Inc., an Innovative Medical Technology Company Focused on Helping Clinicians Advance the Treatment of Brain Cancers, Announced Today its AI Solutions Connect to the Nuance Precision Imaging Network
GROTON, Mass.–(BUSINESS WIRE)–Neosoma, Inc., an innovative medical technology company focused on helping clinicians advance the…
Biote Appoints Debby Morris to Board of Directors
IRVING, Texas–(BUSINESS WIRE)–biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator in preventive…
Core Scientific Announces October Updates
• Operating approximately 243,000 owned and colocated ASIC servers • Produced 1,295 self-mined bitcoins AUSTIN,…
Acronis Disrupts Market with Announcement of New, Simplified MSP-class EDR Solution
Latest Acronis Cyber Protect Cloud release further democratizes advanced security solutions with effective protection for…
Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates
– $174.7 Million Cash and Cash Equivalents at September 30, 2022 – – Over 650…
Novan to Report Third Quarter 2022 Financial Results on November 14, 2022
DURHAM, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
Ceapro Inc. Launches Next Phase of Scale Up for its Disruptive PGX Technology to Pursue Product Development for Nutraceutical and Pharmaceutical Markets
PGX processing unit to be installed at Agri-Food Discovery Place of University of Alberta Alginate…
Nkarta Presents Data Supporting Engineered NK Cell Based Combination Therapies and Next Generation Commercial-Scale Manufacturing Platform at SITC 37th Annual Meeting
Improved Anti-Tumor Activity Demonstrated by the Combination of NKX019 and a CD20-directed Monoclonal Antibody in…
UPDATE — Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
Initial clinical data of AHR antagonist, IK-175, shows treatment is well-tolerated and demonstrates anti-tumor activity…
SciSparc Announced Positive Interim Results Meeting Primary Endpoints at Phase IIa Study in Alzheimer’s Disease Patients with Agitation
Meets primary endpoints- SCI-110 administration was found to be safe at all tested doses SCI-110…